Terug
Dagbereik
€ 29,66
€ 30,96
52-Weeksbereik
€ 2,99
€ 41,89
Volume
89.870
50D / 200D Gem.
€ 26,20
/
€ 17,10
Vorige Slotkoers
€ 29,03
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -21,7 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | 586,9 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 26,00
-14.9%
Forward WPA
-€ 0,28
Omzet Sch.
36 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
-€ 0,25
-€ 0,38 – -€ 0,17
|
41 M | 1 |
| FY2028 |
€ 0,53
€ 0,36 – € 0,80
|
91 M | 1 |
| FY2027 |
-€ 0,50
-€ 0,75 – -€ 0,34
|
38 M | 1 |
Belangrijkste Punten
Net margin of 586,89% shows strong profitability
Negative free cash flow of -20,40M
Capital efficient — spends only -7,30% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-132,06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin586,89%
Op. Margin589,13%
Veiligheid
Debt / Equity
N/A
Current Ratio1,04
Interest Coverage-8,46
Waardering
P/E Ratio
-21,69
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -132,06% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | -11,61M | Net Income (TTM) | -68,13M |
| ROE | N/A | ROA | -101,06% |
| Gross Margin | 100,00% | Operating Margin | 589,13% |
| Net Margin | 586,89% | Free Cash Flow (TTM) | -20,40M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,04 |
| Interest Coverage | -8,46 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -21,69 | P/B Ratio | N/A |
| P/S Ratio | -127,27 | PEG Ratio | -0,06 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,48B | Enterprise Value | 1,48B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | -11,61M | 36,21M | 4,78M | 2,65M | 50.000,0 |
| Net Income | -68,13M | -39,70M | -57,04M | -47,00M | -33,62M |
| EPS (Diluted) | -1,44 | -1,08 | -1,64 | -1,35 | -1,38 |
| Gross Profit | -11,61M | 36,21M | 3,79M | 2,65M | 50.000,0 |
| Operating Income | -68,39M | -26,78M | -46,70M | -52,58M | -36,43M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 67,42M | 93,90M | 59,77M | 101,77M | 134,03M |
| Total Liabilities | 133,12M | 95,74M | 86,81M | 74,98M | 63,56M |
| Shareholders' Equity | -65,70M | -1,84M | -27,05M | 26,79M | 70,47M |
| Total Debt | 50,90M | 50,57M | 53,17M | 46,02M | 48,98M |
| Cash & Equivalents | 49,74M | 75,28M | 41,39M | 83,92M | 119,15M |
| Current Assets | 61,47M | 87,34M | 52,36M | 93,06M | 125,25M |
| Current Liabilities | 58,94M | 49,87M | 37,94M | 36,85M | 19,04M |